Researchers engineered a portable CRISPR-based assay for mpox detection in the wake of the 2025 outbreak in Sierra Leone, as described in the report. The approach is aimed at field diagnostics and epidemic containment by enabling rapid, on-site detection—an operational shift for viral testing that can shorten time to action during localized surges.